Clinical Trial Update: Low Dose IL-2 for the Treatment of Crohn's Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating low-dose interleukin-2 for Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Low-dose Interleukin-2 (interleukin-2)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Crohn Disease | Phase 1, Phase 2 | Status: RECRUITING